Skip to main content

In MI with preserved LVEF, long-term β-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.

Publication ,  Journal Article
Suleiman, B; Granger, CB
Published in: Ann Intern Med
August 2024

Yndigegn T, Lindahl B, Mars K, et al; REDUCE-AMI Investigators. Beta-blockers after myocardial infarction and preserved ejection fraction. N Engl J Med. 2024;390:1372-1381. 38587241.

Duke Scholars

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

August 2024

Volume

177

Issue

8

Start / End Page

JC88

Location

United States

Related Subject Headings

  • Stroke Volume
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Cause of Death
  • Aged
  • Adrenergic beta-Antagonists
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Suleiman, B., & Granger, C. B. (2024). In MI with preserved LVEF, long-term β-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y. Ann Intern Med, 177(8), JC88. https://doi.org/10.7326/ANNALS-24-01163-JC
Suleiman, Belal, and Christopher B. Granger. “In MI with preserved LVEF, long-term β-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.Ann Intern Med 177, no. 8 (August 2024): JC88. https://doi.org/10.7326/ANNALS-24-01163-JC.
Suleiman, Belal, and Christopher B. Granger. “In MI with preserved LVEF, long-term β-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.Ann Intern Med, vol. 177, no. 8, Aug. 2024, p. JC88. Pubmed, doi:10.7326/ANNALS-24-01163-JC.

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

August 2024

Volume

177

Issue

8

Start / End Page

JC88

Location

United States

Related Subject Headings

  • Stroke Volume
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Cause of Death
  • Aged
  • Adrenergic beta-Antagonists